International Psoriasis Council

International Psoriasis Council
subscribe
5   What's New
Search
subscribe
Search

Advancing Knowledge. Improving Care.

tsoi_alex

Alex

Tsoi

,

MS, PhD

Assistant Professor, Department of Dermatology
University of Michigan
Ann Arbor
,
Michigan
,
United States
Councilor Since: March 17, 2023
IPC Councilor
Request an Update
Dr. Tsoi completed his PhD in biomedical science at the Medical University of South Carolina, supervised by Dr. W Jim Zheng. His PhD work focused on developing data integration approaches to enhance prioritization and interpretation of high throughput experimental results. Dr. Tsoi then worked as a research fellow in the Center for Statistical Genetics from the Department of Biostatistics at the University of Michigan. He has worked with Dr. Goncalo Abecasis and Dr. James T. Elder on various genetic and genomics projects for psoriasis. He joined the Department of Dermatology, Department of Computational Medicine & Bioinformatics, and the Department of Biostatistics at the University of Michigan between 2015-2016 as faculty. Dr. Tsoi is interested in investigating complex cutaneous disorders’ pathology and genetic architecture using systems biology approaches. Working with Drs. James T. Elder and Johann Gudjonsson, Dr. Tsoi’s research aims to develop analysis pipelines and computational approaches to provide biological inferences from genetics and genomics data. His work in genetic association studies revealed over 30 novel psoriasis susceptibility regions and highlighted different disease pathways. Recent studies from his lab identified molecular components shaping heterogeneity among psoriatic patients and revealed shared and unique genetic components between psoriasis and its comorbidities.
Last Updated:
03/23/2023

Areas of Interest

Genetics and genomics; heterogeneity comorbidities

IPC Committees / Groups

Symposia Committee

Languages Spoken

English
Recent publications

Featured

Blog

Focus on Psoriasis: A Report from the 2024 Society for Investigative Dermatology (SID) Annual Meeting.

The 2024 Society for Investigative Dermatology (SID) Annual Meeting was held from May 14 to 18, 2024, in Dallas, Texas,…

Read More

Video

Statistical Genomics and Multi-omic Approaches in Advancing Genetic Research for Psoriasis.

Dr. Alex Tsoi discusses the regulatory roles of psoriasis-associated loci keratinocytes, regulatory network and…

Watch Video

Event

Symposium: Advances in Technologies and Analytics in Understanding Psoriasis Pathophysiology.

SOCIETY FOR INVESTIGATIVE DERMATOLOGY (SID) | DALLAS, TEXAS Wednesday, May 15 9:00 - 12:00 CDT Program chairs:…

May 15, 2024
Learn More or Register

Blog

IPC 2023 Think Tank Meeting Report Published in JID Innovations.

Read key highlights from the 2023 International Psoriasis Council (IPC) Think Tank Meeting, summarizing the evolving…

Read More

Video

Genetic Insights into IBD and Psoriasis: Shared Features and Unique Characteristics (Webinar 4, 2023 Series).

Dr. Alex Tsoi discusses IBD as a comorbidity of psoriasis and further examines their existing shared genetic regions.

Watch Video

Video

Comorbidities and Their Causal Relationship.

Dr. Alex Tsoi assesses psoriasis patient statistics, investigating the causal relationship between comorbidities within…

Watch Video

Event

Global Webinar 4: Psoriasis and the Gut.

IPC GLOBAL WEBINAR SERIES Wednesday, December 13 12:30 - 13:30 CET 6:30 - 7:30 EST Program chair: Akimichi Morita,…

December 13, 2023
Learn More or Register

Video

lxekizumab Reduces Key IL-17 and IL-23 Pathway Genes More Rapidly than Guselkumab.

Dr. Tsoi discusses his research on the effects Ixekizumab and Guselkumab has on IL-17/IL-23 pathway gene expression in…

Watch Video

Blog

Meet our Newest Councilors.

Introducing IPC’s newest Councilors for 2023: A cohort of global experts dedicated to improving patient care for…

Read More

Page

Focus on Psoriasis - A Report from the SID Virtual Meeting 2021.

View Report

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »
Monday, April 27, 2026

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026